Welcome to the Breast Tumor Immunology Laboratory (BTIL)
To establish the Dana-Farber and Brigham and Women’s Cancer Center as the pre-eminent institution for breast tumor immunology by elucidating the mechanisms of immune regulation of breast cancer to optimize immunotherapeutic strategies to treat breast cancer thereby reducing recurrence, suffering and mortality.
- To enhance collaborative relationships and opportunities for basic and translational research investigating the immune regulation of breast cancer
- To perform in-depth analysis of animal models and patient samples to efficiently guide rational use and development of immunotherapy modalities for the treatment of breast cancer
- To increase breast cancer patients’ access to trials investigating novel immune-based therapies